US6245347B1
(en)
*
|
1995-07-28 |
2001-06-12 |
Zars, Inc. |
Methods and apparatus for improved administration of pharmaceutically active compounds
|
US6284266B1
(en)
|
1995-07-28 |
2001-09-04 |
Zars, Inc. |
Methods and apparatus for improved administration of fentanyl and sufentanil
|
US6007837A
(en)
*
|
1996-07-03 |
1999-12-28 |
Alza Corporation |
Drug delivery devices and process of manufacture
|
BR9710128A
(pt)
*
|
1996-07-03 |
1999-08-10 |
Alza Corpora |
Dispositivo para fornecimento de medicamento e processo de fabricação
|
TW358031B
(en)
*
|
1997-04-11 |
1999-05-11 |
Akze Nobel N V |
Drug delivery system for 2 or more active substances
|
US6174545B1
(en)
|
1997-07-01 |
2001-01-16 |
Alza Corporation |
Drug delivery devices and process of manufacture
|
GB9720470D0
(en)
*
|
1997-09-25 |
1997-11-26 |
Ethical Pharmaceuticals South |
Inhibition of crystallization in transdermal devices
|
US7066884B2
(en)
*
|
1998-01-08 |
2006-06-27 |
Sontra Medical, Inc. |
System, method, and device for non-invasive body fluid sampling and analysis
|
US8287483B2
(en)
|
1998-01-08 |
2012-10-16 |
Echo Therapeutics, Inc. |
Method and apparatus for enhancement of transdermal transport
|
US20060015058A1
(en)
*
|
1998-01-08 |
2006-01-19 |
Kellogg Scott C |
Agents and methods for enhancement of transdermal transport
|
DE19814084B4
(de)
*
|
1998-03-30 |
2005-12-22 |
Lts Lohmann Therapie-Systeme Ag |
D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
|
SE9801704D0
(sv)
*
|
1998-05-14 |
1998-05-14 |
Bioglan Ab |
Biologically active composition
|
SE9801705D0
(sv)
*
|
1998-05-14 |
1998-05-14 |
Bioglan Ab |
Biologically active composition
|
DE19828273B4
(de)
*
|
1998-06-25 |
2005-02-24 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
|
US6726673B1
(en)
|
1999-05-24 |
2004-04-27 |
Zars, Inc. |
Methods and apparatus for improved administration of testosterone pharmaceuticals
|
US6955819B2
(en)
|
1998-09-29 |
2005-10-18 |
Zars, Inc. |
Methods and apparatus for using controlled heat to regulate transdermal and controlled release delivery of fentanyl, other analgesics, and other medical substances
|
US20040171980A1
(en)
|
1998-12-18 |
2004-09-02 |
Sontra Medical, Inc. |
Method and apparatus for enhancement of transdermal transport
|
US7919109B2
(en)
|
1999-02-08 |
2011-04-05 |
Intarcia Therapeutics, Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
|
US7258869B1
(en)
|
1999-02-08 |
2007-08-21 |
Alza Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
|
ATE322889T1
(de)
†
|
1999-02-08 |
2006-04-15 |
Alza Corp |
Stabile nicht wässerige einphasige visköse vehikeln und formulierungen die diese vehikeln verwenden
|
DE19906152B4
(de)
*
|
1999-02-10 |
2005-02-10 |
Jenapharm Gmbh & Co. Kg |
Wirkstoffhaltige Laminate für Transdermalsysteme
|
US6337328B1
(en)
|
1999-03-01 |
2002-01-08 |
Sepracor, Inc. |
Bupropion metabolites and methods of use
|
US6280763B1
(en)
|
1999-05-10 |
2001-08-28 |
Pierce Management, Llc |
Apparatus and method for transdermal delivery of bupropion
|
FR2793689B1
(fr)
*
|
1999-05-19 |
2001-08-24 |
Pf Medicament |
Dispositif transdermique pour l'administration de testosterone ou d'un de ses derives
|
AU5325000A
(en)
|
1999-06-05 |
2000-12-28 |
David Houze |
Solubility enhancement of drugs in transdermal drug delivery systems and methodsof use
|
CN1195505C
(zh)
|
1999-07-02 |
2005-04-06 |
Lts勒曼治疗系统股份公司 |
以聚硅氧烷及亲两性溶剂为基础的微贮存系统
|
US6453648B1
(en)
|
1999-07-06 |
2002-09-24 |
Zars, Inc. |
Method for manufacturing a heat generating apparatus
|
US6261595B1
(en)
|
2000-02-29 |
2001-07-17 |
Zars, Inc. |
Transdermal drug patch with attached pocket for controlled heating device
|
DE10012908B4
(de)
*
|
2000-03-16 |
2005-03-17 |
Lts Lohmann Therapie-Systeme Ag |
Stabilisierte übersättigte transdermale therapeutische Matrixsysteme und Verfahren zu ihrer Herstellung
|
DE10041478A1
(de)
*
|
2000-08-24 |
2002-03-14 |
Sanol Arznei Schwarz Gmbh |
Neue pharmazeutische Zusammensetzung
|
US20040002482A1
(en)
*
|
2000-08-30 |
2004-01-01 |
Dudley Robert E. |
Androgen pharmaceutical composition and method for treating depression
|
US6503894B1
(en)
|
2000-08-30 |
2003-01-07 |
Unimed Pharmaceuticals, Inc. |
Pharmaceutical composition and method for treating hypogonadism
|
DE10053375C1
(de)
*
|
2000-10-27 |
2002-01-24 |
Lohmann Therapie Syst Lts |
Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen
|
DE10103860B4
(de)
*
|
2001-01-30 |
2004-12-23 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung
|
US20050209208A1
(en)
*
|
2001-04-25 |
2005-09-22 |
The Regents Of The University Of California |
Use of estriol and other estranes, estrogens and estrogen receptor active compositions in the treatment of psoriasis and other autoimmune disorders
|
US20030026830A1
(en)
*
|
2001-05-08 |
2003-02-06 |
Thomas Lauterback |
Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
|
US20030027793A1
(en)
*
|
2001-05-08 |
2003-02-06 |
Thomas Lauterback |
Transdermal treatment of parkinson's disease
|
DE10212864B4
(de)
*
|
2002-03-22 |
2005-12-22 |
Beiersdorf Ag |
Polymermatrizes umfassend ein Mischsystem zur Löslichkeitsvermittlung von pharmazeutischen Wirkstoffen, Verfahren zu deren Herstellung und deren Verwendung
|
US8211462B2
(en)
*
|
2002-07-30 |
2012-07-03 |
Ucb Pharma Gmbh |
Hot-melt TTS for administering rotigotine
|
DE10234673B4
(de)
*
|
2002-07-30 |
2007-08-16 |
Schwarz Pharma Ag |
Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
|
US8246980B2
(en)
*
|
2002-07-30 |
2012-08-21 |
Ucb Pharma Gmbh |
Transdermal delivery system
|
US8246979B2
(en)
|
2002-07-30 |
2012-08-21 |
Ucb Pharma Gmbh |
Transdermal delivery system for the administration of rotigotine
|
KR20050059072A
(ko)
*
|
2002-08-30 |
2005-06-17 |
알자 코포레이션 |
엠보싱 및 기록가능한 다층 지지 구조물
|
US20040086551A1
(en)
|
2002-10-30 |
2004-05-06 |
Miller Kenneth J. |
Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
|
PT1426049E
(pt)
*
|
2002-12-02 |
2005-09-30 |
Sanol Arznei Schwarz Gmbh |
Administracao iontoforetica de rotigotina para o tratamento da doenca de parkinson
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
DE10261696A1
(de)
*
|
2002-12-30 |
2004-07-15 |
Schwarz Pharma Ag |
Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
|
BRPI0407615B8
(pt)
|
2003-02-21 |
2021-05-25 |
Bayer Ip Gmbh |
sistema terapêutico transdérmico estável à radiação ultravioleta
|
DE10334187A1
(de)
*
|
2003-07-26 |
2005-03-03 |
Schwarz Pharma Ag |
Substituierte 2-Aminotetraline zur Behandlung von Depressionen
|
DE10334188B4
(de)
*
|
2003-07-26 |
2007-07-05 |
Schwarz Pharma Ag |
Verwendung von Rotigotin zur Behandlung von Depressionen
|
WO2005025549A2
(en)
*
|
2003-09-10 |
2005-03-24 |
Noven Pharmaceuticals, Inc. |
Multi-layer transdermal drug delivery device
|
GB0322342D0
(en)
*
|
2003-09-23 |
2003-10-22 |
Gamble Reed |
Skin patch
|
CN100457064C
(zh)
*
|
2003-10-28 |
2009-02-04 |
诺芬药品公司 |
透皮递药装置
|
IL159273A0
(en)
*
|
2003-12-09 |
2004-06-01 |
Transpharma Medical Ltd |
Transdermal delivery system for sustained release of polypeptides
|
US8668925B2
(en)
|
2003-12-12 |
2014-03-11 |
Bayer Intellectual Property Gmbh |
Transdermal delivery of hormones without the need of penetration enhancers
|
WO2006023644A2
(en)
*
|
2004-08-20 |
2006-03-02 |
3M Innovative Properties Company |
Transdermal drug delivery device with translucent protective film
|
WO2006041907A2
(en)
*
|
2004-10-08 |
2006-04-20 |
Noven Pharmaceuticals, Inc. |
Transdermal delivery of estradiol
|
ATE471146T1
(de)
*
|
2004-10-21 |
2010-07-15 |
Durect Corp |
Transdermale verabreichungssysteme
|
US8252320B2
(en)
*
|
2004-10-21 |
2012-08-28 |
Durect Corporation |
Transdermal delivery system for sufentanil
|
US20060094944A1
(en)
*
|
2004-10-28 |
2006-05-04 |
Sontra Medical Corporation |
System and method for analyte sampling and analysis with error correction
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
US20060188558A1
(en)
*
|
2005-02-18 |
2006-08-24 |
Mylan Technologies, Inc. |
Transdermal systems having control delivery system
|
US8962013B2
(en)
*
|
2005-05-02 |
2015-02-24 |
Bayer Intellectual Property Gmbh |
Multi-layered transdermal system with triazine UV absorber
|
EP1888001B1
(de)
*
|
2005-06-10 |
2014-08-06 |
Syneron Medical Ltd. |
Patch zur transdermalen wirkstofffreisetzung
|
US8287923B2
(en)
*
|
2005-06-10 |
2012-10-16 |
Medical College Of Georgia Research Institute, Inc. |
Compositions and methods for treating immune disorders
|
TWI419717B
(zh)
*
|
2005-06-17 |
2013-12-21 |
Altea Therapeutics Corp |
滲透傳送系統及其使用方法
|
US9446017B2
(en)
|
2005-08-11 |
2016-09-20 |
Augusta University Research Institute, Inc. |
Compositions and methods for treating herpes simplex virus
|
NO346660B1
(no)
|
2005-10-12 |
2022-11-21 |
Unimed Pharmaceuticals Llc |
Forbedret testosterongel og fremgangsmåte til anvendelse
|
US7432069B2
(en)
*
|
2005-12-05 |
2008-10-07 |
Sontra Medical Corporation |
Biocompatible chemically crosslinked hydrogels for glucose sensing
|
JP5143131B2
(ja)
|
2006-05-30 |
2013-02-13 |
インターシア セラピューティクス,インコーポレイティド |
浸透圧送出システムの二片構成内部チャネル型の流れモジュレータ
|
WO2007147052A2
(en)
|
2006-06-14 |
2007-12-21 |
Dr. Reddy's Laboratories Limited |
Topical compositions
|
PL2359808T3
(pl)
|
2006-08-09 |
2013-10-31 |
Intarcia Therapeutics Inc |
Osmotyczne systemy dostawcze i zespoły tłokowe
|
US9114133B2
(en)
|
2006-08-25 |
2015-08-25 |
U.S. Dept. Of Veterans Affairs |
Method of improving diastolic dysfunction
|
PT2117521E
(pt)
|
2006-11-03 |
2012-09-10 |
Durect Corp |
Sistemas de administração transdérmica que compreendem bupivacaína
|
US8812071B2
(en)
*
|
2007-03-07 |
2014-08-19 |
Echo Therapeutics, Inc. |
Transdermal analyte monitoring systems and methods for analyte detection
|
US20080226698A1
(en)
*
|
2007-03-16 |
2008-09-18 |
Mylan Technologies, Inc. |
Amorphous drug transdermal systems, manufacturing methods, and stabilization
|
MX2009011123A
(es)
|
2007-04-23 |
2009-11-02 |
Intarcia Therapeutics Inc |
Formulaciones de suspensiones de peptidos insulinotropicos y sus usos.
|
JP2010525881A
(ja)
|
2007-04-27 |
2010-07-29 |
エコー セラピューティクス, インコーポレイテッド |
被検体の検知または経皮的薬物送達のための皮膚透過装置
|
CA2704164A1
(en)
*
|
2007-10-29 |
2009-05-07 |
Transpharma Medical Ltd. |
Vertical patch drying
|
EP2240155B1
(de)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe
|
US20090269403A1
(en)
*
|
2008-04-24 |
2009-10-29 |
Shaked Ze Ev |
Oral contraceptive dosage forms and methods of making such dosage forms
|
US20090291127A1
(en)
*
|
2008-05-21 |
2009-11-26 |
Jianye Wen |
Transdermal anti-dementia active agent formulations and methods for using the same
|
KR101590209B1
(ko)
*
|
2008-05-30 |
2016-02-01 |
밀란 인크. |
안정화 경피 약물 전달 시스템
|
US8231906B2
(en)
|
2008-07-10 |
2012-07-31 |
Noven Pharmaceuticals, Inc. |
Transdermal estrogen device and delivery
|
CN102164601A
(zh)
*
|
2008-09-30 |
2011-08-24 |
帝国制药美国公司 |
经皮延长给药多奈哌齐组合物及其使用方法
|
WO2010042152A2
(en)
*
|
2008-10-06 |
2010-04-15 |
Mylan Technologies, Inc. |
Amorphous rotigotine transdermal system
|
CA2757302A1
(en)
*
|
2009-04-01 |
2010-10-07 |
Andrew Crockett |
Methods for treating myofascial, muscle, and/or back pain
|
CN102427792A
(zh)
*
|
2009-05-04 |
2012-04-25 |
扎斯制药公司 |
治疗与神经瘤、神经卡压及其他病况相关联的疼痛的方法
|
US9186334B2
(en)
|
2009-05-04 |
2015-11-17 |
Nuvo Research Inc. |
Heat assisted lidocaine and tetracaine for transdermal analgesia
|
WO2011014775A1
(en)
|
2009-07-31 |
2011-02-03 |
The Brigham And Women's Hospital, Inc. |
Modulation of sgk1 expression in th17 cells to modulate th17-mediated immune responses
|
NZ598686A
(en)
|
2009-09-28 |
2014-05-30 |
Intarcia Therapeutics Inc |
Rapid establishment and/or termination of substantial steady-state drug delivery
|
US20100178307A1
(en)
*
|
2010-01-13 |
2010-07-15 |
Jianye Wen |
Transdermal anti-dementia active agent formulations and methods for using the same
|
RU2648827C2
(ru)
*
|
2010-03-28 |
2018-03-28 |
Эвестра, Инк. |
Внутривлагалищное устройство для доставки лекарственного средства
|
JP5766475B2
(ja)
|
2010-03-30 |
2015-08-19 |
日東電工株式会社 |
貼付製剤およびその製造方法
|
AU2011237592B2
(en)
|
2010-04-08 |
2016-10-27 |
Emory University |
Substituted androst-4-ene diones
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
WO2012129237A2
(en)
|
2011-03-20 |
2012-09-27 |
Trustees Of Boston University |
Therapeutic agent for emphysema and copd
|
EP2704726B1
(de)
|
2011-05-04 |
2018-10-31 |
Trustees of Boston University |
Protonenantriebskraftstimulation zur potenzierung von aminoglycosid-antibiotika gegen persistente bakterien
|
JPWO2012165254A1
(ja)
|
2011-05-31 |
2015-02-23 |
久光製薬株式会社 |
ロピニロール含有貼付剤及びその包装体
|
US9155710B2
(en)
|
2011-05-31 |
2015-10-13 |
Hisamitsu Pharmaceutical Co., Inc. |
Ropinirole-containing patch and package thereof
|
US20140227293A1
(en)
|
2011-06-30 |
2014-08-14 |
Trustees Of Boston University |
Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
|
EP2543370A1
(de)
|
2011-07-06 |
2013-01-09 |
Georgia Health Sciences University Research Institute, Inc. |
Zusammensetzungen und Verfahren zur Behandlung des Herpes-simplex-Virus
|
CA2790749A1
(en)
|
2011-09-29 |
2013-03-29 |
Nitto Denko Corporation |
Manufacturing method of patch preparation
|
US9243037B2
(en)
|
2011-11-10 |
2016-01-26 |
Trustees Of Boston College |
Gramicidin a mutants that function as antibiotics with improved solubility and reduced toxicity
|
EP3936133A1
(de)
|
2011-11-23 |
2022-01-12 |
TherapeuticsMD, Inc. |
Natürliche kombinationshormonersatzformulierungen und therapien
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
DE102011090178A1
(de)
*
|
2011-12-30 |
2013-07-04 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System mit geringer Neigung zur Spontankristallisation
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
JP5270035B1
(ja)
*
|
2012-12-06 |
2013-08-21 |
久光製薬株式会社 |
貼付剤及びその製造方法
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
JP5307931B1
(ja)
|
2012-12-27 |
2013-10-02 |
久光製薬株式会社 |
貼付剤及びその製造方法
|
CN103919755B
(zh)
*
|
2013-01-15 |
2019-10-18 |
江苏康倍得药业股份有限公司 |
妥洛特罗透皮贴剂及其制备方法
|
CN103933018A
(zh)
*
|
2013-01-18 |
2014-07-23 |
江苏康倍得药业有限公司 |
一种透皮给药系统
|
WO2014130922A1
(en)
|
2013-02-25 |
2014-08-28 |
Trustees Of Boston University |
Compositions and methods for treating fungal infections
|
JP5415645B1
(ja)
|
2013-06-28 |
2014-02-12 |
久光製薬株式会社 |
貼付剤の製造方法、貼付剤及び包装体
|
WO2015027146A1
(en)
|
2013-08-22 |
2015-02-26 |
The General Hospital Corporation |
Inhibitors of human 12/15-lipoxygenase
|
US11382883B2
(en)
|
2013-08-29 |
2022-07-12 |
Trustees Of Boston University |
Intermediate metabolism products to potentiate aminoglycoside antibiotics in bacterial infections
|
KR20170005819A
(ko)
|
2014-05-22 |
2017-01-16 |
쎄러퓨틱스엠디, 인코퍼레이티드 |
천연 복합 호르몬 대체 제형 및 요법
|
US10493027B2
(en)
*
|
2014-08-07 |
2019-12-03 |
Mucodel Pharma Llc |
Chemically stable compositions of a pharmaceutical active agent in a multi- chambered delivery system for mucosal delivery
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
US9844558B1
(en)
|
2015-04-30 |
2017-12-19 |
Amag Pharmaceuticals, Inc. |
Methods of reducing risk of preterm birth
|
EP3303286B1
(de)
|
2015-06-01 |
2023-10-04 |
Cedars-Sinai Medical Center |
An rela von nf-kb anbindende verbindungen zur verwendung bei der behandlung von krebs
|
AU2016270984B2
(en)
|
2015-06-03 |
2021-02-25 |
Intarcia Therapeutics, Inc. |
Implant placement and removal systems
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
BR112018001441A2
(pt)
|
2015-07-28 |
2018-09-11 |
Vyome Biosciences Pvt Ltd |
antibacterianos terapêuticos e profiláticos
|
WO2017059070A1
(en)
|
2015-09-29 |
2017-04-06 |
Amag Pharmaceuticals, Inc. |
Crystalline and amorphous form of 17-a- hydroxyprogesterone caproate
|
AU2017239645A1
(en)
|
2016-04-01 |
2018-10-18 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical composition
|
US10286077B2
(en)
|
2016-04-01 |
2019-05-14 |
Therapeuticsmd, Inc. |
Steroid hormone compositions in medium chain oils
|
CN109310743A
(zh)
|
2016-05-16 |
2019-02-05 |
因塔西亚制药公司 |
胰高血糖素受体选择性多肽及其使用方法
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
EP3565580B1
(de)
|
2017-01-03 |
2024-03-06 |
i2o Therapeutics, Inc. |
Kontinuierlicher verabreichung von exenatid und co-verabreichung von acetaminophen, ethinylestradiol oder levonorgestrel
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|